Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 101 results for "cipla"

Cipla hits 3-1/2-month low, technicals signal further downside

Cipla hits 3-1/2-month low, technicals signal further downside

Drug maker Cipla Ltd falls as much as 1.98 pct to 562.7 rupees, to its lowest since Jan 3. Stock breaks below a support around 575 rupees, the 61.8 pct Fibonacci projection of wave 1. Stock has also broken below the support from its 200-day Simple Moving ... Sify, 2 days ago

103 images for cipla

Sify, 2 days ago
Money Control, 6 days ago
Money Control, 1 week ago
Money Control, 2 weeks ago
Money Control, 2 weeks ago
Money Control, 2 weeks ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 3 weeks ago, 1 month ago
Money Control

Stocks in the news: IOC, Cipla, Nestle, Indian Hume Pipe, Reliance Power

IOC | Cipla | Nestle | Indian Hume Pipe | Reliance Power are stocks, which are in news today.
 Money Control6 days ago Stocks in the news: Reliance, Infosys, Cipla, Arshiya, IOL Chem, Laurel, Majesco  Money Control1 week ago Stocks in the news: Cipla, HUL, Voltas, MEP Infra, GE Power, SMS Pharma, Deepak Fert  Money Control2 weeks ago Stocks in the news: Cipla, Hero Moto, GMR, Ratanmani Metals, McNally Bharat  Money Control2 weeks ago
Money Control

Cipla Q4 PAT seen up 7.3% to Rs 326.3 cr: ICICI Securities

Net Sales are expected to increase by 5.6 percent Q-o-Q (up 17.9 percent Y-o-Y) to Rs 3852.5 crore, according to ICICI Securities. Cipla to report net profit at 326.3 crore up 7.3% quarter-on-quarter.
 Money Control6 days ago Cipla's Q3 net profit jumps by 44% to Rs 375 cr  Business Standard2 months ago Cipla net profit up 44 per cent in Q3  Prokerala2 months ago Cipla Q3 Net jumps 43.85% to Rs 374.83 crore  Business Standard2 months ago
Money Control

Cipla arm completes acquisition of South Africa-based firm

Drug firm Cipla said today it's subsidiary in South Africa has completed the acquisition of Anmarate (Pty) Ltd, South Africa, a deal estimated at around ZAR 26 million.
 DNA1 week ago Cipla acquires South Africa-based firm for ZAR 26 mln  DNA3 weeks ago Cipla to acquire South African Pharma company- Anmarate  Business Standard3 weeks ago Cipla gains as subsidiary concludes its stake sale  India Infoline2 months ago

Margin expansion crucial for Cipla's stock

Continued efforts on growth in global markets is positive and will accrue benefits over time
 Business Standard1 week ago

Bitter pill for Cipla after bulk deal

Cipla fell 0.94% to Rs 583 at 14:10 IST on BSE after a bulk deal of 17.22 lakh shares was executed on the scrip at Rs 586.50 per share at 10:57 IST on BSE.
 Business Standard1 week ago

French Presidential election and Oil Price Fall Impact Global Markets

Posted by Equitymaster Investors were cautious ahead of the first round of the French Presidential elections ending next week. Fall in crude oil prices amidst oversupply concerns also adversely affected Global markets this week. Crude prices fell by 6.4% this ...
 Equitymaster.com1 day ago Global markets Remain Choppy as Geopolitical Tensions Rise  Equitymaster.com1 week ago US Strikes on Syria Keep a Lid on Global Financial Markets  Equitymaster.com2 weeks ago Global Stock Markets Remain Range Bound  Equitymaster.com1 month ago

Weekly Wrap: Sensex, Nifty shed about 0.3% after lackluster sessions

Concerns about geopolitical tensions, weakness in global markets and caution ahead of key results rendered price movements quite sluggish in the Indian stock market during the week ended 21 April 2017. Recording losses on three of the five sessions, the key ...
 Sify1 day ago Weekly Wrap: Market drifts lower on global cues, disappointing economic data, Infosys guidance  Sify1 week ago Weekly Wrap: Sensex shed 0.8% on profit taking  Sify4 weeks ago Weekly Wrap: Sensex hits 2-year high, Nifty scales new peak  Sify1 month ago

Pharma companies seen reporting weak numbers

Pharmaceutical companies are expected to report a weak fourth quarter as they had to grapple with issues like higher remediation cost on US FDA-ticked facilities, lower generic drug prices in the US and the demonetisation impact on domestic sales. The BSE ...
 The Financial Chronicle6 days ago Rising rupee another risk for Indian pharma  Business Standard1 week ago

Market Live: BSE Sensex, Nifty remain firm; ABB, Divis Labs top midcap gainers

Coal India, Reliance Industries, LT, BHEL, Cipla, TCS, BPCL, IOC and Bharti Infratel were early gainers.
 Money Control1 week ago Market Live: Nifty holds 9200, Midcap outperforms; Q4 earnings eyed  Money Control1 week ago Market Live: Nifty opens above 9200, Sensex firm on short covering; LT gains  Money Control1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less